Most common adverse reactions (≥ 40%) are: vomiting, rash (all), abdominal pain, diarrhea, nausea, dry skin, fatigue, musculoskeletal pain, pyrexia, acneiform rash, stomatitis, headache, paronychia, and pruritus.
from FDA,2024.01
By targeting and inhibiting the activity of MEK protein, Koselugo effectively cuts off the signaling pathway of tumor cells, thereby inhibiting their abnormal proliferation, bringi···【more】
Article source:Lucius LaosRelease date:2024-08-23Recommended:150
Koselugoinhibits tumor cell proliferation by inhibiting MEK protein activity, blocking cell signaling, and significantly improving the quality of life of patients.Are the side effe···【more】
Article source:Lucius LaosRelease date:2024-08-23Recommended:150
Koselugo is a targeted therapy drug primarily used to treat a specific subtype of neurofibromatosis type 1 (NF1), known as neurofibromatosis agenesis.What are the side effects of K···【more】
Article source:Lucius LaosRelease date:2024-08-23Recommended:152
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: